Edmond De Rothschild Holding S.A. Abbott Laboratories Transaction History

Edmond De Rothschild Holding S.A.

  • $6.04 Billion
  • Q3 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 81,630 shares of ABT stock, worth $9.14 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
81,630
Previous 81,630 -0.0%
Holding current value
$9.14 Million
Previous $8.48 Million 9.71%
% of portfolio
0.15%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$100.73 - $112.44 $133,165 - $148,645
-1,322 Reduced 1.59%
81,630 $8.48 Million
Q1 2024

May 08, 2024
SELL
$109.52 - $120.96 $5.43 Million - $6 Million
-49,574 Reduced 37.41%
82,952 $9.43 Million
Q4 2023

Feb 12, 2024
SELL
$90.19 - $110.4 $22,547 - $27,600
-250 Reduced 0.19%
132,526 $14.6 Million
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $1.47 Million - $1.77 Million
15,419 Added 13.14%
132,776 $12.9 Million
Q2 2023

Aug 09, 2023
BUY
$100.78 - $112.29 $1.52 Million - $1.7 Million
15,117 Added 14.79%
117,357 $12.8 Million
Q1 2023

May 11, 2023
BUY
$96.86 - $114.01 $18,693 - $22,003
193 Added 0.19%
102,240 $10.4 Million
Q4 2022

Feb 09, 2023
BUY
$95.06 - $111.52 $25,095 - $29,441
264 Added 0.26%
102,047 $11.2 Million
Q3 2022

Nov 09, 2022
BUY
$96.76 - $112.03 $72,860 - $84,358
753 Added 0.75%
101,783 $9.85 Million
Q2 2022

Aug 12, 2022
SELL
$102.07 - $123.37 $1.88 Million - $2.27 Million
-18,400 Reduced 15.41%
101,030 $11 Million
Q1 2022

May 10, 2022
SELL
$114.02 - $139.04 $2.62 Million - $3.2 Million
-23,000 Reduced 16.15%
119,430 $14.1 Million
Q4 2021

Feb 10, 2022
SELL
$115.53 - $141.46 $2.87 Million - $3.51 Million
-24,827 Reduced 14.84%
142,430 $20 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $1.96 Million - $2.17 Million
16,803 Added 11.17%
167,257 $19.8 Million
Q2 2021

Aug 11, 2021
SELL
$105.79 - $124.53 $716,198 - $843,068
-6,770 Reduced 4.31%
150,454 $17.4 Million
Q1 2021

May 17, 2021
SELL
$108.84 - $128.23 $4.21 Million - $4.96 Million
-38,700 Reduced 19.75%
157,224 $18.8 Million
Q4 2020

Feb 12, 2021
BUY
$105.0 - $114.42 $344,085 - $374,954
3,277 Added 1.7%
195,924 $21.5 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $1.04 Million - $1.26 Million
11,300 Added 6.23%
192,647 $21 Million
Q2 2020

Aug 07, 2020
BUY
$76.57 - $98.0 $4.02 Million - $5.15 Million
52,520 Added 40.77%
181,347 $16.6 Million
Q1 2020

May 15, 2020
BUY
$62.82 - $91.86 $71,426 - $104,444
1,137 Added 0.89%
128,827 $10.2 Million
Q4 2019

Feb 14, 2020
SELL
$78.51 - $87.4 $895,014 - $996,360
-11,400 Reduced 8.2%
127,690 $11.1 Million
Q3 2019

Nov 14, 2019
BUY
$81.84 - $88.74 $114,576 - $124,236
1,400 Added 1.02%
139,090 $11.6 Million
Q2 2019

Aug 14, 2019
SELL
$72.88 - $85.0 $5.96 Million - $6.95 Million
-81,741 Reduced 37.25%
137,690 $11.6 Million
Q1 2019

May 13, 2019
BUY
$66.22 - $80.06 $860,595 - $1.04 Million
12,996 Added 6.3%
219,431 $17.5 Million
Q4 2018

Feb 14, 2019
BUY
$65.56 - $74.27 $2.87 Million - $3.25 Million
43,704 Added 26.86%
206,435 $14.9 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $366,137 - $441,700
6,021 Added 3.84%
162,731 $11.9 Million
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $877,942 - $968,985
-15,250 Reduced 8.87%
156,710 $9.56 Million
Q1 2018

May 15, 2018
BUY
$56.27 - $63.62 $804,661 - $909,766
14,300 Added 9.07%
171,960 $10.3 Million
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $5.09 Million - $5.45 Million
-94,870 Reduced 37.57%
157,660 $9 Million
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $12.1 Million - $13.5 Million
252,530
252,530 $13.5 Million

Others Institutions Holding ABT

# of Institutions
3,187
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $196B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email